84
Participants
Start Date
December 31, 2016
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Dimethandrolone Undecanoate
Single doses of DMAU in castor oil/benzyl benzoate injections intramuscularly (IM) (80 mg, 240 mg, 480 mg, and 800 mg) or administered subcutaneously (SC) (50 mg, 100 mg and 200 mg).
Placebo
Placebo injections that look like the DMAU injections but with no active ingredients
RECRUITING
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance
RECRUITING
University of Washington Medical Center & Health Sciences, Seattle
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
OTHER
University of Washington
OTHER
Premier Research
OTHER